AsterlaunchesPrecisionOncologyClinicsinBangalore:RevolutionizingCancerCarewithAdvancedsoftware-DrivenPatientManagement
Aster在班加罗尔推出精准肿瘤诊所：通过先进的软件驱动的患者管理彻底改变癌症护理
AI-PoweredCancerCare:HarnessingAdvancedDataAnalysisforEarlyDetection,PreventionandBetterOutcomes
人工智能支持的癌症护理：利用先进的数据分析进行早期发现、预防和更好的结果
GlobalCollaborationforCancerResearch:AsterCancerGridPartnerswithleadingPharma,BiotechandResearchInstitutionstoDriveInnovationandshareknowledgeworldwide.
全球癌症研究合作：Aster癌症网格与领先的制药、生物技术和研究机构合作，推动全球创新和知识共享。
AsterDMHealthcare,oneofthelargestintegratedhealthcareprovidersinIndialaunchedthreenoteworthyinitiatives–PrecisionOncologyClinics,theAsterCancerGrid,andOncoCollectbytheDr.RameshNimmegaddaCancerFoundation,markingasignificantadvancementinIndia’scancertreatmentlandscapeattheAsterCancerConclave2024.Theconclave,attendedbyleadingnational&internationaloncologists,researchers,andindustryexperts,highlightedthelatestadvancementsincancercareandtreatment.
。
Thetheme,PRISM:PrecisioninSolidMalignancies,underscoredthecriticalroleofprecisionmedicineinaddressingcancer..
主题“棱镜：实体恶性肿瘤的精确性”强调了精准医学在解决癌症方面的关键作用。。
Thenewlylaunchedinitiativesaimtorevolutionizecancercarebyofferingpersonalized,data-driven,andresearch-basedtreatments,emphasizinggenomicapproachestoimprovepatientoutcomes.Theseprogramsrepresentaleapforwardinensuringaccessible,cutting-edgecancertherapieswhilefosteringcollaborativeresearchandstreamliningpatientdatacollection..
新推出的举措旨在通过提供个性化，数据驱动和基于研究的治疗方法来彻底改变癌症护理，强调基因组方法以改善患者预后。这些计划代表了在确保可获得的尖端癌症治疗同时促进合作研究和简化患者数据收集方面的一个飞跃。。
ThePrecisionOncologyClinicswillfocusoncancercarealignedwiththegenomicprofileofthepatient.Suchtreatmentapproachesareadeparturefromthecommonlyusedtreatmentapproachesinwhichcancerpatientsaretreateduniformlybasedonthediseasecondition.Herethepatient’scancertherapyiscustomized,baseduponthegenomicmutationsinthetumourusingpreciseoncologicalapproacheswhichinawayreducethedetrimentaleffectsoftreatmentwhileenhancingefficiency..
精准肿瘤诊所将专注于与患者基因组特征相一致的癌症护理。。在这里，患者的癌症治疗是定制的，基于肿瘤中的基因组突变，使用精确的肿瘤学方法，在某种程度上减少了治疗的有害影响，同时提高了效率。。
TheAsterCancerGridwillenablecollaborativeresearch,andmulti-centerclinicaltrialsandstandardizecancercare.Inaddition,itwillaggregatedatafromallAsterHospitals.TheAsterCancerGridwillactivelyseekpartnershipswithpharmaceuticalcompanies,biotechfirms,andresearchinstitutionstoadvancecancerresearchanddevelopment.
Aster癌症网格将实现协作研究、多中心临床试验和癌症护理标准化。此外，它将汇总所有Aster医院的数据。Aster癌症网格将积极寻求与制药公司、生物技术公司和研究机构的合作伙伴关系，以推进癌症研究和开发。
Thenetwork’scollaborationwithinternationalresearchcentreswillfacilitatetheexchangeofknowledgeandbestpracticesonaglobalscaleandleadthewayforjointfundingapplications,grantopportunitiesandfundedresearchinitiativesincancer..
该网络与国际研究中心的合作将促进全球范围内的知识和最佳实践交流，并为联合资助申请、赠款机会和资助的癌症研究举措铺平道路。。
TheOncoCollectSoftwarebyDr.RameshNimmegaddaCancerFoundationwaslaunchedatallAsterHospitalsinBangaloreandpromisestorevolutionizeoncologydatamanagement.Itisaplatformthatstandardizespracticemanagementbyplacingallpatientdatainonelocation,creatingauniformdatabaseandprovidingoutcomeanalysisthusensuringevidence-basedtreatmentbyclinicians..
拉梅什·尼梅加达癌症基金会（Dr.RameshNimmegddaCancerFoundation）的OncoCollect软件在班加罗尔的所有Aster医院推出，有望彻底改变肿瘤学数据管理。它是一个平台，通过将所有患者数据放在一个位置，创建统一的数据库并提供结果分析来标准化实践管理，从而确保临床医生进行循证治疗。。
Dr.AzadMoopen,Founder&Chairman,AsterDMHealthcare,expressed,“Bycollaboratingwithworld-renownedoncologists,researchers,researchinstitutions,andleadingpharmaandbiotechcompanies,weareacceleratingthedevelopmentandimplementationofinnovativetherapiesandinterventionsincancercare.
AsterDMHealthcare创始人兼主席AzadMoopen博士表示：“通过与世界著名的肿瘤学家、研究人员、研究机构以及领先的制药和生物技术公司合作，我们正在加速癌症护理创新疗法和干预措施的开发和实施。
ThiscollectiveeffortaimstoestablishIndiaasagloballeaderincancerresearchandtreatmentthroughcutting-edgeinnovationandstrategicpartnerships.AttheheartofthisinitiativeistheAsterInternationalInstituteofOncology,astate-of-the-art,multidisciplinaryfacilitythatmeetsinternationalstandardsforcancercare.
这项集体努力旨在通过尖端创新和战略伙伴关系，使印度成为癌症研究和治疗领域的全球领导者。这一举措的核心是Aster国际肿瘤研究所，这是一家最先进的多学科机构，符合国际癌症护理标准。
Asterhasalwaysbeenafirstadopterofadvancedtechnologies,consistentlyleadingthewayinintegratingthelatestmedicaladvancementsforthebenefitofpatients.Theinstitutewillplayapivotalroleinoperationalizingnewtechnologiesandmethodologies,includingtherecentlyintroducedIntra-OperativeElectronRadiationTherapyatAsterWhitefield,Bangalore.
Aster一直是先进技术的第一个采用者，在整合最新医学进步以造福患者方面始终处于领先地位。该研究所将在实施新技术和方法方面发挥关键作用，包括最近在班加罗尔AsterWhitefield引入的术中电子放射治疗。
Together,theseadvancementswilloffercomprehensive,world-classcancercare.Ourvisionisclear:topositionIndiaasapremierdestinationforeffectiveandtransformativecancertreatment.”.
总之，这些进步将提供全面的世界级癌症护理。我们的愿景很明确：将印度定位为有效和变革性癌症治疗的首要目的地。”。
Dr.SomashekharS.P,GlobalDirector-AsterInternationalInstituteofOncology,Chairman–MedicalAdvisorBoard,AsterDMHealthcare,explained,“Byintegratinggeneticprofilingintocancertreatment,weareabletooffertherapiesthatarebothmoreeffectiveandlesstoxicforpatients.Thisisacrucialstepforwardinprovidingpersonalizedcarethattrulyaddressestheuniquenatureofeachpatient’scancer.Thecityandthecountryareinurgentneedofthismethodology.
Aster国际肿瘤研究所全球主任、AsterDMHealthcare医疗顾问委员会主席SomashekharS.P博士解释说：“通过将基因分析整合到癌症治疗中，我们能够提供对患者更有效且毒性更低的治疗方法。这是在提供个性化护理方面迈出的关键一步，真正解决了每位患者癌症的独特性质。城市和国家迫切需要这种方法。
AttheAsterInternationalInstituteofOncology,weareabletotreattheentirespectrumofcancerandofferawiderangeofoncology-relatedservicesincludingradiationandelectrontherapyunderthesameroof.Also,roboticsurgeryattheInstitutegreatlyintensifiesaccuracyandprecisionincancertreatment.
Asteroffersagreatopportunityforpatientstoseekadvancedcancertreatmentinthecountryitself”..
Aster为患者在国内寻求晚期癌症治疗提供了一个很好的机会”。。
Dr.ZebaMoopen,Non-ExecutiveDirector,AsterDMHealthcare,commented,“TheAsterCancerGridwilloptimizeresourceutilization,enhancepatientrecruitmentforclinicaltrials,andpromoteseamlesscollaborationamongoncologistsacrossournetwork.WithcancercasesrisingatanalarmingrateinIndia,theneedforeffectiveandtimelyinterventionshasneverbeenmorecritical.
Thisinitiativewillrevolutionizecancerresearchandtreatmentbyenablingdata-driveninsights,andusingAI,wecananalysevastamountsofpatientdatatouncoverpatternsandpredictoutcomesmoreaccurately.AtAster,wehavealwaysprioritizedpatientcare,andthroughcontinuousinnovation,weareleveragingAIanddatacollectiontoimprovetreatmentprecision,acceleratesolutions,andultimatelydeliverbetteroutcomes,improvingthequalityoflifeforeverypatientweserve.”.
这一举措将通过实现数据驱动的见解来彻底改变癌症研究和治疗，并且使用人工智能，我们可以分析大量患者数据，以更准确地揭示模式和预测结果。在Aster，我们始终优先考虑患者护理，通过不断创新，我们正在利用AI和数据收集来提高治疗精度，加速解决方案，并最终提供更好的结果，提高我们服务的每位患者的生活质量。”。
Dr.CNPatil,HODandLeadConsultant–MedicalOncology&Haemato-Oncology,AsterWhitefieldHospital,added,“OncoCollectisanadvancedsystemthatwewillusetoensureprecisiontreatmentofpatientsbytrackingtheirtreatmentoutcomesinrealtimeandmodifyingtheirtreatmentplanswhenevernecessary.
AsterWhitefieldHospital肿瘤学和血液肿瘤学首席顾问CNPatil博士补充道：“OncoCollect是一个先进的系统，我们将通过实时跟踪患者的治疗结果并在必要时修改治疗计划来确保对患者进行精确治疗。
India’sprowessissoftwareanditistheidealsettingtodrivehealthandcancercareinparticularthroughsoftwaredrivendataanalysisthatwouldensuregreaterautomationandhenceaccuracyinunderstandingcancerdynamics.Softwareensuresreliabilitythatmayescapehumaninterventionattimesalthoughacombinationofbothistheperfectstrategytoguaranteeagainsterrorsintreatmentmethodologies.
印度的实力是软件，它是推动健康和癌症护理的理想环境，特别是通过软件驱动的数据分析，这将确保更高的自动化程度，从而确保理解癌症动态的准确性。软件确保了可靠性，有时可能会逃避人为干预，尽管两者的结合是保证治疗方法不出现错误的完美策略。
Therightbalancewillsurelygenerateasuccessfuloutcome.”.
ThelaunchesattheAsterCancerConclave2024markaparadigmshiftforcancercareinIndia.Theseinitiatives—relatingtoprecisionmedicine,collaborativeresearch,anddata-basedtreatment—havethepotentialtotransformtheoncologycarelandscape.Withnewpatient-centredtreatmentmodels,increasedcooperationonresearchandimproveddatareportingacrossthenetwork,Asteraimstocreatenewrealitiesinwhichcancertreatmentbecomesnotonlymoreefficient,butalsomoreavailableforthepopulationofIndia..